Indicated for metabolic liver disorders: liver Non-Alcoholic Steatohepatitis (NASH): Liver inflammation and damage caused by a buildup of fat. 🩸 Non-Alcoholic Fatty Liver Disease (NAFLD): Particularly in patients with comorbidities like Type 2 Diabetes Mellitus or Dyslipidemia (high triglycerides).

Dosage and administration

Packaging: 4 mg Tablets (Pack of 45). ⚠️ ADMINISTRATION: 💊 Dosage: Standard dose is one tablet (4 mg) once daily. 🕒 Timing: Can be taken with or without food. Swallow whole with water. 📅 Duration: Long-term therapy is often required for liver regeneration; follow the physician's prescription.

Pregnancy and breastfeeding (safety not established). Hypersensitivity to Saroglitazar or any excipients. Severe renal or hepatic impairment (requires medical supervision).

Generally well-tolerated, but side effects may include: 🤕 General: Asthenia (weakness), Pyrexia (mild fever). 🤢 Gastrointestinal: Gastritis, dyspepsia, abdominal discomfort. 🤧 Respiratory: Nasopharyngitis.

Bilypsa — Saroglitazar 4 mg, 45 pcs, Zydus Celexa

100% original product

Active ingredient

Saroglitazar

Manufacturer

Zydus Celexa

Dosage 4 mg

Dosage form Tablets

Tablets per pack 45

Bilypsa (Saroglitazar) 4 mg

Name: Bilypsa
Brand: Zydus Celexa
SKU: PROD-108
Price: 1494 UAH
Availability: InStock

1494₴ ~~1758₴~~ -15%

Bilypsa (Saroglitazar 4 mg) is the world's first approved medication specifically for Non-Alcoholic Steatohepatitis (NASH).

Manufacturer: Zydus Lifesciences (India). It is a breakthrough therapeutic agent designed to treat "fatty liver" conditions not caused by alcohol consumption.

Mechanism of Action ("Dual PPAR Agonist"):

Saroglitazar is a dual peroxisome proliferator-activated receptor (PPAR) agonist acting on both α (alpha) and γ (gamma) subtypes. The alpha action reduces high triglycerides and liver fat accumulation, while the gamma action improves insulin sensitivity and controls blood sugar. It effectively halts liver fibrosis and reduces inflammation.

✅ Key Benefit: Significant reduction in liver fat content and normalization of liver enzymes (ALT/AST).

Indicated for metabolic liver disorders:

liver Non-Alcoholic Steatohepatitis (NASH): Liver inflammation and damage caused by a buildup of fat.
🩸 Non-Alcoholic Fatty Liver Disease (NAFLD): Particularly in patients with comorbidities like Type 2 Diabetes Mellitus or Dyslipidemia (high triglycerides).

Packaging: 4 mg Tablets (Pack of 45).

⚠️ ADMINISTRATION:

💊 Dosage: Standard dose is one tablet (4 mg) once daily.
🕒 Timing: Can be taken with or without food. Swallow whole with water.
📅 Duration: Long-term therapy is often required for liver regeneration; follow the physician's prescription.

Pregnancy and breastfeeding (safety not established).
Hypersensitivity to Saroglitazar or any excipients.
Severe renal or hepatic impairment (requires medical supervision).

Generally well-tolerated, but side effects may include:

🤕 General: Asthenia (weakness), Pyrexia (mild fever).
🤢 Gastrointestinal: Gastritis, dyspepsia, abdominal discomfort.
🤧 Respiratory: Nasopharyngitis.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 07.03.2026

Active ingredient

Saroglitazar

Manufacturer

Zydus Celexa

Dosage 4 mg

Dosage form Tablets

Tablets per pack 45

100% original product

Delivery across Ukraine

Alternatives

What Customers Say

No reviews yet

Your review can be the first!

Bilypsa (Saroglitazar) 4 mg

Similar products

Liposem

What Customers Say

No reviews yet

Contact us

Request a call